(Q35027762)

5 August 2017

1 reference

title

Homocysteine and arterial disease. Experimental mechanisms (English)

1 reference

5 August 2017

Judith W Cook

1

1 reference

5 August 2017

Lloyd M Taylor

2

1 reference

5 August 2017

Susan L Orloff

3

1 reference

5 August 2017

Gregory J Landry

4

1 reference

5 August 2017

Gregory L Moneta

5

1 reference

5 August 2017

John M Porter

6

1 reference

5 August 2017

1 May 2002

1 reference

5 August 2017

Vascular Pharmacology

1 reference

5 August 2017

38

1 reference

5 August 2017

5

1 reference

5 August 2017

293-300

1 reference

Association of mild hyperhomocysteinemia with cardiac graft vascular disease.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Chemotactic response of monocytes to thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Identification of a thrombin sequence with growth factor activity on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine mediated endothelial cell toxicity and its amelioration

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Renal metabolism of homocysteine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Acute hyperhomocysteinaemia and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

The effect of elevated homocysteine levels on adrenergic vasoconstriction of human resistance arteries: the role of the endothelium and reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Endothelial cell dysfunction in homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocystine uptake in isolated rat renal cortical tubules

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Disorders of homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

St Cyres lecture. Endothelium in control

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Failure to produce atherosclerosis in Macaca radiata on a high-methionine, high-fat, pyridoxine-deficient diet.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine increases cyclin-dependent kinase in aortic rat tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine and endothelial dysfunction: a link with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Cardiac allograft vascular disease after orthotopic heart transplantation: methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocyst(e)ine impairs endocardial endothelial function

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Stimulation of endothelial nitric oxide production by homocyst(e)ine

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine, oxidative stress, and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900254-9

7 January 2021

10.1016/S1537-1891(02)00254-9

Identifiers

DOI

1 reference

5 August 2017

1 reference